Related Experiment Video
Updated: Aug 23, 2025

Computerized Adaptive Testing System of Functional Assessment of Stroke
Published on: January 7, 2019
Development and calibration data for the Medication Adherence Item Bank: a new computer adaptive test for persons
Noelle E Carlozzi1, Michael A Kallen2, Jonathan Troost3
1Department of Physical Medicine & Rehabilitation, Center for Clinical Outcomes Development and Application (CODA), University of Michigan, North Campus Research Complex, 2800 Plymouth Road, Building NCRC B14, Room G216, Ann Arbor, MI, 48109-2800, USA. carlozzi@med.umich.edu.
Purpose:
To develop a new computer adaptive test that evaluates important aspects of medication adherence for persons with type 2 diabetes mellitus.
Methods:
Two hundred and twenty-five people with type 2 diabetes mellitus completed 41 items related to medication adherence.
Results:
Exploratory analysis supported the essential unidimensionality of the initial item pool. Five items were deleted due to low item-adjusted total score correlations (resulting in 36 items). Confirmatory factor analysis supported the retention of 27 items. A graded response model identified no items for exclusion, based on misfit. No items were flagged for meaningful differential item functioning (DIF). The final item bank is comprised of 27 items; an associated 6-item short form was constructed that balanced both psychometric factors (e.g., item information values) and clinical input. Initial analysis of the simulated CAT and static short form supported both the reliability (i.e., internal consistency and test-retest reliability) and validity (i.e., convergent, discriminant, and known groups) of both administration formats.
Conclusions:
The new medication adherence item bank provides a reliable and valid assessment of the ability to take medications accurately among people with T2DM; it will be available in early 2023 through healthmeasures.net.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

